DCAF1 and melanoma: Since VprBP-mediated H2AT120p displays a sharp reduction in G361 and MeWo melanoma cells treated with VprBP inhibitor B32B3 (Fig. 2c and Additional file 3: Fig. S3c), we wondered whether the growth of melanoma cells is also suppressed by such B32B3 treatments.